Consolidated Statement Of Cash Flows

CHUGAI PHARMACEUTICAL CO., LTD. - Filing #7271855

Concept 2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2022-12-31
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss)
JPY
387,317,000,000 JPY
387,317,000,000 JPY
JPY
387,317,000,000 JPY
JPY
325,472,000,000 JPY
325,472,000,000 JPY
JPY
JPY
325,472,000,000 JPY
JPY
Other
-6,422,000,000 JPY
-2,244,000,000 JPY
Subtotal
548,078,000,000 JPY
585,998,000,000 JPY
Income taxes paid
-100,477,000,000 JPY
-176,074,000,000 JPY
Net cash provided by (used in) operating activities
447,600,000,000 JPY
409,925,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-50,415,000,000 JPY
-71,948,000,000 JPY
Proceeds from sale of property, plant and equipment
-510,000,000 JPY
19,346,000,000 JPY
Purchase of intangible assets
-3,974,000,000 JPY
-2,310,000,000 JPY
Purchase of investment securities
-3,092,000,000 JPY
-278,000,000 JPY
Proceeds from sale of investment securities
JPY
342,000,000 JPY
Net cash provided by (used in) investing activities
-227,365,000,000 JPY
-37,290,000,000 JPY
Cash flows from financing activities
Proceeds from exercise of employee share options
168,000,000 JPY
217,000,000 JPY
Other
328,000,000 JPY
JPY
Net cash provided by (used in) financing activities
-141,006,000,000 JPY
-139,331,000,000 JPY
Cash and cash equivalents
540,202,000,000 JPY
458,674,000,000 JPY
222,169,000,000 JPY
Effect of exchange rate changes on cash and cash equivalents
2,299,000,000 JPY
3,202,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.